{"entity":{"type":"insider","cik":"0001258176","url":"/insider/0001258176","json_url":"/insider/0001258176.json","name":"HSIA DAVID C","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":38,"n_filings":19,"first":"2003-09-19","last":"2008-05-16","span_basis":"filed_date"},"name_variants":[{"name":"HSIA DAVID C","source":"filing","n_filings":19,"first_seen":"2003-09-19","last_seen":"2008-05-16"}],"transactions":[{"id":3514001,"accession":"0001179110-08-009998","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-08-009998","line_url":"/filing/0001179110-08-009998","is_derivative":false,"issuer_cik":"0000884629","issuer_name":"WATSON PHARMACEUTICALS INC","issuer_ticker":"WPI","issuer_name_source":null,"issuer_url":"/issuer/0000884629","owner_cik":"0001258176","owner_name":"HSIA DAVID C","owner_display_name":"HSIA DAVID C","owner_url":"/insider/0001258176","role":"Officer (Sr. VP, Scientific Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Scientific Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Scientific Affairs","security_title":"Common Stock, par value $0.0033","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":28.6483,"price_display":"28.65","price_state":"stated","total_value":2864830.0,"total_display":"2,864,830.00","total_whole":"2,864,830","shares_owned_after":954218.0,"shares_owned_after_display":"954,218","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-05-15","filed_date":"2008-05-16","scope":"insider","n_lines":2},{"id":1334273,"accession":"0001179110-05-017888","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-05-017888","line_url":"/filing/0001179110-05-017888","is_derivative":false,"issuer_cik":"0000884629","issuer_name":"WATSON PHARMACEUTICALS INC","issuer_ticker":"WPI","issuer_name_source":null,"issuer_url":"/issuer/0000884629","owner_cik":"0001258176","owner_name":"HSIA DAVID C","owner_display_name":"HSIA DAVID C","owner_url":"/insider/0001258176","role":"Officer (Sr. VP, Scientific Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Scientific Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Scientific Affairs","security_title":"Common Stock, par value $0.0033","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":35.41775,"price_display":"35.42","price_state":"stated","total_value":1416710.0,"total_display":"1,416,710.00","total_whole":"1,416,710","shares_owned_after":1004218.0,"shares_owned_after_display":"1,004,218","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-09-12","filed_date":"2005-09-13","scope":"insider","n_lines":2},{"id":578633,"accession":"0001179110-04-005864","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-04-005864","line_url":"/filing/0001179110-04-005864","is_derivative":false,"issuer_cik":"0000884629","issuer_name":"WATSON PHARMACEUTICALS INC","issuer_ticker":"WPI","issuer_name_source":null,"issuer_url":"/issuer/0000884629","owner_cik":"0001258176","owner_name":"HSIA DAVID C","owner_display_name":"HSIA DAVID C","owner_url":"/insider/0001258176","role":"Officer (Sr. VP, Scientific Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Scientific Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Scientific Affairs","security_title":"Common Stock, par value $0.0033","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":112500.0,"total_display":"112,500.00","total_whole":"112,500","shares_owned_after":1024218.0,"shares_owned_after_display":"1,024,218","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-03-11","filed_date":"2004-03-11","scope":"insider","n_lines":2},{"id":365245,"accession":"0001179110-04-005386","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-04-005386","line_url":"/filing/0001179110-04-005386","is_derivative":false,"issuer_cik":"0000884629","issuer_name":"WATSON PHARMACEUTICALS INC","issuer_ticker":"WPI","issuer_name_source":null,"issuer_url":"/issuer/0000884629","owner_cik":"0001258176","owner_name":"HSIA DAVID C","owner_display_name":"HSIA DAVID C","owner_url":"/insider/0001258176","role":"Officer (Sr. VP, Scientific Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Scientific Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Scientific Affairs","security_title":"Common Stock, par value $0.0033","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":47.2612,"price_display":"47.26","price_state":"stated","total_value":118153.0,"total_display":"118,153.00","total_whole":"118,153","shares_owned_after":1025468.0,"shares_owned_after_display":"1,025,468","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-03-04","filed_date":"2004-03-04","scope":"insider","n_lines":2},{"id":254825,"accession":"0001179110-04-004769","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-04-004769","line_url":"/filing/0001179110-04-004769","is_derivative":false,"issuer_cik":"0000884629","issuer_name":"WATSON PHARMACEUTICALS INC","issuer_ticker":"WPI","issuer_name_source":null,"issuer_url":"/issuer/0000884629","owner_cik":"0001258176","owner_name":"HSIA DAVID C","owner_display_name":"HSIA DAVID C","owner_url":"/insider/0001258176","role":"Officer (Sr. VP, Scientific Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Scientific Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Scientific Affairs","security_title":"Common Stock, par value $0.0033","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":45.9604,"price_display":"45.96","price_state":"stated","total_value":114901.0,"total_display":"114,901.00","total_whole":"114,901","shares_owned_after":1026718.0,"shares_owned_after_display":"1,026,718","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-02-26","filed_date":"2004-02-27","scope":"insider","n_lines":2},{"id":339443,"accession":"0001179110-04-004253","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-04-004253","line_url":"/filing/0001179110-04-004253","is_derivative":false,"issuer_cik":"0000884629","issuer_name":"WATSON PHARMACEUTICALS INC","issuer_ticker":"WPI","issuer_name_source":null,"issuer_url":"/issuer/0000884629","owner_cik":"0001258176","owner_name":"HSIA DAVID C","owner_display_name":"HSIA DAVID C","owner_url":"/insider/0001258176","role":"Officer (Sr. VP, Scientific Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Scientific Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Scientific Affairs","security_title":"Common Stock, par value $0.0033","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":47.6976,"price_display":"47.70","price_state":"stated","total_value":119244.0,"total_display":"119,244.00","total_whole":"119,244","shares_owned_after":1027968.0,"shares_owned_after_display":"1,027,968","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-02-19","filed_date":"2004-02-20","scope":"insider","n_lines":2},{"id":571883,"accession":"0001179110-04-003398","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-04-003398","line_url":"/filing/0001179110-04-003398","is_derivative":false,"issuer_cik":"0000884629","issuer_name":"WATSON PHARMACEUTICALS INC","issuer_ticker":"WPI","issuer_name_source":null,"issuer_url":"/issuer/0000884629","owner_cik":"0001258176","owner_name":"HSIA DAVID C","owner_display_name":"HSIA DAVID C","owner_url":"/insider/0001258176","role":"Officer (Sr. VP, Scientific Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Scientific Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Scientific Affairs","security_title":"Common Stock, par value $0.0033","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":48.2976,"price_display":"48.30","price_state":"stated","total_value":120744.0,"total_display":"120,744.00","total_whole":"120,744","shares_owned_after":584064.0,"shares_owned_after_display":"584,064","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-02-12","filed_date":"2004-02-13","scope":"insider","n_lines":2},{"id":523626,"accession":"0001179110-04-002584","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-04-002584","line_url":"/filing/0001179110-04-002584","is_derivative":false,"issuer_cik":"0000884629","issuer_name":"WATSON PHARMACEUTICALS INC","issuer_ticker":"WPI","issuer_name_source":null,"issuer_url":"/issuer/0000884629","owner_cik":"0001258176","owner_name":"HSIA DAVID C","owner_display_name":"HSIA DAVID C","owner_url":"/insider/0001258176","role":"Officer (Sr. VP, Scientific Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Scientific Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Scientific Affairs","security_title":"Common Stock, par value $0.0033","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":45.9268,"price_display":"45.93","price_state":"stated","total_value":114817.0,"total_display":"114,817.00","total_whole":"114,817","shares_owned_after":585314.0,"shares_owned_after_display":"585,314","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-02-05","filed_date":"2004-02-06","scope":"insider","n_lines":2},{"id":471150,"accession":"0001179110-04-001995","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-04-001995","line_url":"/filing/0001179110-04-001995","is_derivative":false,"issuer_cik":"0000884629","issuer_name":"WATSON PHARMACEUTICALS INC","issuer_ticker":"WPI","issuer_name_source":null,"issuer_url":"/issuer/0000884629","owner_cik":"0001258176","owner_name":"HSIA DAVID C","owner_display_name":"HSIA DAVID C","owner_url":"/insider/0001258176","role":"Officer (Sr. VP, Scientific Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Scientific Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Scientific Affairs","security_title":"Common Stock, par value $0.0033","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":46.6792,"price_display":"46.68","price_state":"stated","total_value":116698.0,"total_display":"116,698.00","total_whole":"116,698","shares_owned_after":1031718.0,"shares_owned_after_display":"1,031,718","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-01-29","filed_date":"2004-01-29","scope":"insider","n_lines":2},{"id":482456,"accession":"0001179110-04-001677","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-04-001677","line_url":"/filing/0001179110-04-001677","is_derivative":false,"issuer_cik":"0000884629","issuer_name":"WATSON PHARMACEUTICALS INC","issuer_ticker":"WPI","issuer_name_source":null,"issuer_url":"/issuer/0000884629","owner_cik":"0001258176","owner_name":"HSIA DAVID C","owner_display_name":"HSIA DAVID C","owner_url":"/insider/0001258176","role":"Officer (Sr. VP, Scientific Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Scientific Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Scientific Affairs","security_title":"Common Stock, par value $0.0033","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":48.72,"price_display":"48.72","price_state":"stated","total_value":121800.0,"total_display":"121,800.00","total_whole":"121,800","shares_owned_after":1032968.0,"shares_owned_after_display":"1,032,968","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-01-22","filed_date":"2004-01-23","scope":"insider","n_lines":2},{"id":336448,"accession":"0001179110-04-001282","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-04-001282","line_url":"/filing/0001179110-04-001282","is_derivative":false,"issuer_cik":"0000884629","issuer_name":"WATSON PHARMACEUTICALS INC","issuer_ticker":"WPI","issuer_name_source":null,"issuer_url":"/issuer/0000884629","owner_cik":"0001258176","owner_name":"HSIA DAVID C","owner_display_name":"HSIA DAVID C","owner_url":"/insider/0001258176","role":"Officer (Sr. VP, Scientific Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Scientific Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Scientific Affairs","security_title":"Common Stock, par value $0.0033","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":47.1868,"price_display":"47.19","price_state":"stated","total_value":117967.0,"total_display":"117,967.00","total_whole":"117,967","shares_owned_after":1034218.0,"shares_owned_after_display":"1,034,218","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-01-15","filed_date":"2004-01-15","scope":"insider","n_lines":2},{"id":623437,"accession":"0001179110-04-000284","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-04-000284","line_url":"/filing/0001179110-04-000284","is_derivative":false,"issuer_cik":"0000884629","issuer_name":"WATSON PHARMACEUTICALS INC","issuer_ticker":"WPI","issuer_name_source":null,"issuer_url":"/issuer/0000884629","owner_cik":"0001258176","owner_name":"HSIA DAVID C","owner_display_name":"HSIA DAVID C","owner_url":"/insider/0001258176","role":"Officer (Sr. VP, Scientific Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Scientific Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Scientific Affairs","security_title":"Common Stock, par value $0.0033","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":45.7132,"price_display":"45.71","price_state":"stated","total_value":114283.0,"total_display":"114,283.00","total_whole":"114,283","shares_owned_after":1035468.0,"shares_owned_after_display":"1,035,468","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-01-02","filed_date":"2004-01-05","scope":"insider","n_lines":2},{"id":178409,"accession":"0001179110-03-013476","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-03-013476","line_url":"/filing/0001179110-03-013476","is_derivative":false,"issuer_cik":"0000884629","issuer_name":"WATSON PHARMACEUTICALS INC","issuer_ticker":"WPI","issuer_name_source":null,"issuer_url":"/issuer/0000884629","owner_cik":"0001258176","owner_name":"HSIA DAVID C","owner_display_name":"HSIA DAVID C","owner_url":"/insider/0001258176","role":"Officer (Sr. VP, Scientific Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Scientific Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Scientific Affairs","security_title":"Common Stock, par value $0.0033","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":45.47,"price_display":"45.47","price_state":"stated","total_value":113675.0,"total_display":"113,675.00","total_whole":"113,675","shares_owned_after":1036718.0,"shares_owned_after_display":"1,036,718","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-12-26","filed_date":"2003-12-29","scope":"insider","n_lines":2},{"id":145058,"accession":"0001179110-03-012995","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-03-012995","line_url":"/filing/0001179110-03-012995","is_derivative":false,"issuer_cik":"0000884629","issuer_name":"WATSON PHARMACEUTICALS INC","issuer_ticker":"WPI","issuer_name_source":null,"issuer_url":"/issuer/0000884629","owner_cik":"0001258176","owner_name":"HSIA DAVID C","owner_display_name":"HSIA DAVID C","owner_url":"/insider/0001258176","role":"Officer (Sr. VP, Scientific Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Scientific Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Scientific Affairs","security_title":"Common Stock, par value $0.0033","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":112500.0,"total_display":"112,500.00","total_whole":"112,500","shares_owned_after":1037968.0,"shares_owned_after_display":"1,037,968","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-12-18","filed_date":"2003-12-18","scope":"insider","n_lines":2},{"id":10296,"accession":"0001179110-03-011937","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-03-011937","line_url":"/filing/0001179110-03-011937","is_derivative":false,"issuer_cik":"0000884629","issuer_name":"WATSON PHARMACEUTICALS INC","issuer_ticker":"WPI","issuer_name_source":null,"issuer_url":"/issuer/0000884629","owner_cik":"0001258176","owner_name":"HSIA DAVID C","owner_display_name":"HSIA DAVID C","owner_url":"/insider/0001258176","role":"Officer (Sr. VP, Scientific Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Scientific Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Scientific Affairs","security_title":"Common Stock, par value $0.0033","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":47.596,"price_display":"47.60","price_state":"stated","total_value":118990.0,"total_display":"118,990.00","total_whole":"118,990","shares_owned_after":1039218.0,"shares_owned_after_display":"1,039,218","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-12-04","filed_date":"2003-12-04","scope":"insider","n_lines":2},{"id":121854,"accession":"0001179110-03-011522","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-03-011522","line_url":"/filing/0001179110-03-011522","is_derivative":false,"issuer_cik":"0000884629","issuer_name":"WATSON PHARMACEUTICALS INC","issuer_ticker":"WPI","issuer_name_source":null,"issuer_url":"/issuer/0000884629","owner_cik":"0001258176","owner_name":"HSIA DAVID C","owner_display_name":"HSIA DAVID C","owner_url":"/insider/0001258176","role":"Officer (Sr. VP, Scientific Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Scientific Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Scientific Affairs","security_title":"Common Stock, par value $0.0033","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":47.1176,"price_display":"47.12","price_state":"stated","total_value":117794.0,"total_display":"117,794.00","total_whole":"117,794","shares_owned_after":1040468.0,"shares_owned_after_display":"1,040,468","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-11-28","filed_date":"2003-12-01","scope":"insider","n_lines":2},{"id":50367,"accession":"0001179110-03-011084","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-03-011084","line_url":"/filing/0001179110-03-011084","is_derivative":false,"issuer_cik":"0000884629","issuer_name":"WATSON PHARMACEUTICALS INC","issuer_ticker":"WPI","issuer_name_source":null,"issuer_url":"/issuer/0000884629","owner_cik":"0001258176","owner_name":"HSIA DAVID C","owner_display_name":"HSIA DAVID C","owner_url":"/insider/0001258176","role":"Officer (Sr. VP, Scientific Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Scientific Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Scientific Affairs","security_title":"Common Stock, par value $0.0033","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":45.32,"price_display":"45.32","price_state":"stated","total_value":113300.0,"total_display":"113,300.00","total_whole":"113,300","shares_owned_after":1041718.0,"shares_owned_after_display":"1,041,718","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-11-20","filed_date":"2003-11-20","scope":"insider","n_lines":2},{"id":10269,"accession":"0001179110-03-010806","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-03-010806","line_url":"/filing/0001179110-03-010806","is_derivative":false,"issuer_cik":"0000884629","issuer_name":"WATSON PHARMACEUTICALS INC","issuer_ticker":"WPI","issuer_name_source":null,"issuer_url":"/issuer/0000884629","owner_cik":"0001258176","owner_name":"HSIA DAVID C","owner_display_name":"HSIA DAVID C","owner_url":"/insider/0001258176","role":"Officer (Sr. VP, Scientific Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Scientific Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Scientific Affairs","security_title":"Common Stock, par value $0.0033","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":112500.0,"total_display":"112,500.00","total_whole":"112,500","shares_owned_after":1042968.0,"shares_owned_after_display":"1,042,968","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-11-13","filed_date":"2003-11-14","scope":"insider","n_lines":2},{"id":156764,"accession":"0001179110-03-007617","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-03-007617","line_url":"/filing/0001179110-03-007617","is_derivative":false,"issuer_cik":"0000884629","issuer_name":"WATSON PHARMACEUTICALS INC","issuer_ticker":"WPI","issuer_name_source":null,"issuer_url":"/issuer/0000884629","owner_cik":"0001258176","owner_name":"HSIA DAVID C","owner_display_name":"HSIA DAVID C","owner_url":"/insider/0001258176","role":"Officer (Sr. VP, Scientific Affairs)","role_mark":"O","role_mark_label":"Officer (Sr. VP, Scientific Affairs)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr. VP, Scientific Affairs","security_title":"Common Stock, par value $0.0033","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":112500.0,"total_display":"112,500.00","total_whole":"112,500","shares_owned_after":1044218.0,"shares_owned_after_display":"1,044,218","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-09-18","filed_date":"2003-09-19","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":38,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":38,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":38},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000884629","name":"WATSON PHARMACEUTICALS INC","url":"/issuer/0000884629","role":"Officer (Sr. VP, Scientific Affairs)","n_filings":19,"first_seen":"2003-09-19","last_seen":"2008-05-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001258176","retrieved_at":"2026-08-23T02:02:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}